Roots Analysis has done a detailed study on Prefilled Syringe Fill / Finish Services Market, 2020-2030, covering key aspects of the industry’s evolution andidentifying potential future growth opportunities.
To order this 260+ page report, which features 60+ figuresand 110+ tables, please visit this link
Key Market Insights
§ Over 100 companies across the globe claim to providecontract fill / finish services for prefilled syringes; close to 50% of theseservice providers are large companies with over 500 employees.
§ The market landscape features the presence of well-established players in the domain, most of which claim to operate at variousscales of operation and are located in different geographies.
§ In order to acquire competencies across the supply chainand cater to the evolving needs of clients, companies offering services acrossdifferent scales of operation have established presence in various geographies.
§ Fill / finish service providers are actively investing inexpansion projects to upgrade existing capabilities and capacity; severalpartnerships, mostly focused on offering contract services, have also beenforged.
§ As expected, majority of the installed contract fill /finish capacity for prefilled syringes belongs to the large service providers,accounting for around 80% of the available global capacity.
§ The demand for fill / finish services for prefilledsyringes is likely to steadily increase in the coming years; we believestakeholders may have to expand their respective capacities to ensure aconsistent supply.
§ An evaluation of prefilled syringe combination productdevelopers revealed that Europe and North America have emerged as the keyregions for partnering opportunities for fill / finish service providers.
§ Caste Study: Around 70 prefilled syringes are beingmanufactured by large companies, most of which claim to be capable of fabricating syringe barrels from both glassand plastic materials.
§ We expect drug developers to continue to outsource theirfill / finish operations in the short to mid term, resulting in an annualizedgrowth at the rate of over 8% within the contract services market.
§ In the long-term, the projected opportunity for the fill /finish service providers for prefilled syringes is likely to be welldistributed across various types of barrel chambers, scales of operation andgeographical regions.
For more information, please visit https://www.rootsanalysis.com/reports/view_document/prefilled-syringe-fill-finish-services/301.html
Table of Contents
1. PREFACE
1.1. Chapter Overview
1.2. Scope ofthe Report
1.3. ResearchMethodology
1.4. ChapterOutlines
2. EXECUTIVE SUMMARY
3. INTRODUCTION
3.1. ChapterOverview
3.2. Introductionto Prefilled Syringes
3.2.1. Classificationof Prefilled Syringes
3.2.2. Manufacturingof Prefilled Syringes
3.2.3. Advantagesof Prefilled Syringes
3.2.3.1. Benefits toHealthcare Professionals and End Users
3.2.3.2. Benefits toManufacturers
3.3. Fill /Finish Processing of Prefilled Syringes
3.3.1. StepsInvolved in Fill / Finish Process
3.3.2. Methods ofFilling and Stoppering of Prefilled Syringes
3.3.3. PrefilledSyringe Filling Technologies
3.4. FactorsContributing to the Growth of Prefilled Syringe Fill / Finish Market
3.5. Need forOutsourcing Fill / Finish Operations of Sterile Injectables
3.6. Advantagesof Outsourcing Fill / Finish Services
3.7. RisksAssociated with Outsourcing of Fill / Finish Operations
3.8. KeyConsiderations While Selecting a Fill / Finish Service Provider
4. MARKETLANDSCAPE
4.1. ChapterOverview
4.2. PrefilledSyringe Fill / Finish Service Providers: Overall Market Landscape
4.2.1. Analysis byYear of Establishment
4.2.2. Analysis byCompany Size
4.2.3. Analysis byScale of Operation
4.2.4. Analysis byLocation of Headquarters
4.2.5. Analysis byLocation of Prefilled Syringe Fill / Finish Facilities
4.2.6. Analysis byType of Drug Molecule
4.2.7. Analysis bySyringe Barrel Material
4.2.8. Analysis bySyringe Fill Volume
4.2.9. Analysis byAdditional Services Offered
4.2.10. Heat Map:Analysis by Company Size and Location of Headquarters
4.2.11. LogoLandscape: Analysis by Company Size and Type of Drug Molecule
4.2.12. GeographicalMap: Analysis by Scale of Operation and Location of Fill / Finish Facilities
4.2.13. Grid Representation: Distribution by Year ofEstablishment, Company Size and Type of Drug Molecule
5. PREFILLEDSYRINGE FILL / FINISH SERVICE PROVIDERS IN NORTH AMERICA: COMPANY PROFILES
5.1. ChapterOverview
5.2. AjinomotoBio-Pharma Services
5.2.1. Company Overview
5.2.2. RecentDevelopments and Future Outlook
5.3. AMRI
5.3.1. Company Overview
5.3.2. RecentDevelopments and Future Outlook
5.4. BioPharmaSolutions
5.4.1. Company Overview
5.4.2. RecentDevelopments and Future Outlook
5.5. EmergentBioSolutions
5.5.1. Company Overview
5.5.2. Recent Developmentsand Future Outlook
5.6. Patheon(a Thermo Fisher Scientific Company)
5.6.1. Company Overview
5.6.2. RecentDevelopments and Future Outlook
6. PREFILLEDSYRINGE FILL / FINISH SERVICE PROVIDERS IN EUROPE: COMPANY PROFILES
6.1. ChapterOverview
6.2. ConsortMedical
6.2.1. Company Overview
6.2.2. RecentDevelopments and Future Outlook
6.3. EVER Pharma
6.3.1. Company Overview
6.3.2. RecentDevelopments and Future Outlook
6.4. GlaxoSmithKline
6.4.1. Company Overview
6.4.2. RecentDevelopments and Future Outlook
6.5. IDTBiologika
6.5.1. Company Overview
6.5.2. RecentDevelopments and Future Outlook
6.6. RentschlerBiopharma
6.6.1. Company Overview
6.6.2. RecentDevelopments and Future Outlook
6.7. Siegfried
6.7.1. Company Overview
6.7.2. RecentDevelopments and Future Outlook
6.8. VetterPharma
6.8.1. Company Overview
6.8.2. RecentDevelopments and Future Outlook
7. PREFILLEDSYRINGE FILL / FINISH SERVICE PROVIDERS IN ASIA-PACIFIC: COMPANY PROFILES
7.1. ChapterOverview
7.2. Biocon
7.2.1. Company Overview
7.2.2. RecentDevelopments and Future Outlook
7.3. IntasPharmaceuticals
7.3.1. Company Overview
7.3.2. RecentDevelopments and Future Outlook
7.4. KemwellBiopharma
7.4.1. Company Overview
7.4.2. Recent Developmentsand Future Outlook
7.5. SquarePharmaceuticals
7.5.1. Company Overview
7.5.2. RecentDevelopments and Future Outlook
8. PREFILLEDSYRINGE FILL / FINISH SERVICE PROVIDERS: RECENT DEVELOPMENTS
8.1. ChapterOverview
8.2. List ofExpansions
8.2.1. Analysis byYear of Expansion
8.2.2. Analysis byType of Expansion
8.2.3. Analysis byExpanded Scale of Operation
8.2.4. Analysis byLocation of Expansion Project
8.2.5. Analysis byType of Drug Molecule Involved
8.2.6. Analysis byAdditional Services Offered (Expansion Specific)
8.3. PartnershipModels
8.4. List ofPartnerships and Collaborations
8.4.1. Analysis byYear of Partnership
8.4.2. Analysis byType of Partnership
8.4.3. Analysis byScale of Operation (Deal Specific)
8.4.4. Analysis byAdditional Services Offered (Deal Specific)
9. CAPACITYANALYSIS
9.1. ChapterOverview
9.2. Assumptionsand Methodology
9.3. Global,Prefilled Syringe Fill / Finish Capacity (by Number of Units)
9.3.1. Analysis byCompany Size
9.3.2. Analysis byScale of Operation
9.3.3. Analysis byLocation of Headquarters
9.3.4. Analysis byLocation of Fill / Finish Facilities
9.3.5. Analysis byType of Drug Molecule
9.4. Global,Prefilled Syringe Fill / Finish Capacity (by Volume)
9.4.1. Analysis byCompany Size (Manufacturer)
9.4.2. Analysis byScale of Operation
9.4.3. Analysis byLocation of Headquarters
9.4.4. Analysis byLocation of Fill / Finish Facilities
9.4.5. Analysis byType of Drug Molecule
10. DEMANDANALYSIS
10.1. ChapterOverview
10.2. Assumptionsand Methodology
10.3. GlobalDemand for Prefilled Syringes Fill / Finish Services
10.3.1. Global Demandfor Commercialized Prefilled Syringes Fill / Finish Services
10.3.1.1. Analysis by Geography
10.3.1.1.1. North America
10.3.1.1.2. Europe
10.3.1.1.3. Asia-Pacific
10.3.1.1.4. Latin America
10.3.1.1.5. Middle East and Africa
10.3.1.2. Analysis by Syringe Barrel Material
10.3.1.3. Analysis by Number of Barrel Chambers
10.3.1.4. Analysis by Type of Drug Molecule
10.3.1.5. Analysis by Therapeutic Area
10.3.1.6. Analysis by Specialty Syringes
10.3.2. Global Demandfor Clinical Prefilled Syringes Fill / Finish Services
10.4. Demand andSupply Analysis
10.4.1. Demand andSupply Analysis (Scenario 1)
10.4.2. Demand andSupply Analysis (Scenario 2)
10.4.3. Demand andSupply Analysis (Scenario 3)
11. GEOGRAPHICALASSESSMENT OF DEMAND AND SUPPLY
11.1. ChapterOverview
11.2. Assumptionsand Key Parameters
11.3. Demand andSupply Assessment in North America
11.3.1. KeyGeographies
11.3.1.1. US
11.4. Demand andSupply Assessment in Europe
11.4.1. KeyGeographies
11.4.1.1. France
11.4.1.2. Germany
11.4.1.3. Italy
11.5. Demand andSupply Assessment in Asia-Pacific Region
11.5.1. KeyGeographies
11.5.1.1. India
11.5.1.2. Japan
12. LIKELYPARTNER ANALYSIS
12.1. ChapterOverview
12.2. Methodologyand Key Parameters
12.3. LikelyPartner Analysis
12.3.1. Opportunitiesin North America
12.3.1.1. Most Likely Partners for Prefilled Syringe Fill /Finish Service Providers
12.3.1.2. Likely Partners for Prefilled Syringe Fill /Finish Service Providers
12.3.2. Opportunitiesin Europe
12.3.2.1. Most Likely Partners for Prefilled Syringe Fill /Finish Service Providers
12.3.2.2. Likely Partners for Prefilled Syringe Fill /Finish Service Providers
12.3.3. Opportunitiesin Asia-Pacific and Rest of the World
12.3.3.1. Most Likely Partners for Prefilled Syringe Fill /Finish Service Providers
12.3.3.2. Likely Partners for Prefilled Syringe Fill /Finish Service Providers
13. MARKETSIZING AND OPPORTUNITY ANALYSIS
13.1. ChapterOverview
13.2. ForecastMethodology and Key Assumptions
13.3. OverallPrefilled Syringe Fill / Finish Services Market, 2020-2030
13.3.1. PrefilledSyringe Fill / Finish Services Market: Distribution by Scale of Operation,2020-2030
13.3.2. PrefilledSyringe Fill / Finish Services Market: Distribution by Geographical Region
13.3.2.1. Prefilled Syringe Fill / Finish Services Marketin North America
13.3.2.2. Prefilled Syringe Fill / Finish Services Marketin Europe
13.3.2.3. Prefilled Syringe Fill / Finish Services Marketin Asia-Pacific
13.3.2.4. Prefilled Syringe Fill / Finish Services MarketLatin America
13.3.2.5. Prefilled Syringe Fill / Finish Services Marketin Middle East and Africa
13.3.3. PrefilledSyringe Fill / Finish Services Market: Distribution by Type of Drug Molecule,2020-2030
13.3.4. PrefilledSyringe Fill / Finish Services Market: Distribution by Therapeutic Area
13.3.5. PrefilledSyringe Fill / Finish Services Market: Distribution by Syringe Barrel Material,2020-2030
13.3.6. Prefilled Syringe Fill / Finish ServicesMarket: Distribution by Number of Barrel Chambers, 2020-2030
14. FUTUREGROWTH OPPORTUNITIES
14.1. ChapterOverview
14.2. GrowingInjectable Drugs Pipeline
14.3. Increase inPopularity of Prefilled Syringes
14.4. Rise inPreference for Outsourcing Fill / Finish Activities
14.5. Advances inAseptic Fill / Finish Technologies
14.6. GrowingOpportunities in the Asia-Pacific Region
15. CASE STUDY:PREFILLED SYRINGE MANUFACTURERS
15.1. Chapter Overview
15.2. PrefilledSyringes: List of Available / Under Development Devices
15.2.1. Analysis bySyringe Barrel Material
15.2.2. Analysis byNumber of Barrel Chambers
15.2.3. Analysis byType of Needle System
15.2.4. Analysis byBarrel Volume
15.3. PrefilledSyringes: List of Manufacturers
15.3.1. Analysis byYear of Establishment
15.3.2. Analysis byLocation of Headquarters
16. CONCLUDINGREMARKS
16.1. ChapterOverview
16.2. KeyTakeaways
17. INTERVIEWTRANSCRIPTS
17.1. ChapterOverview
17.2. Bio Elpida
17.2.1. CompanySnapshot
17.2.2. InterviewTranscript: Gilles Devillers, President and Cofounder
17.3. IntasPharmaceuticals
17.3.1. CompanySnapshot
17.3.2. InterviewTranscript: Kirti Maheshwari, Chief Technical Officer
17.4. IDTBiologika
17.4.1. CompanySnapshot
17.4.2. InterviewTranscript: Gregor Kawaletz, Chief Commercial Officer
17.5. Takeda
17.5.1. CompanySnapshot
17.5.2. Interview Transcript: Michael Dekner,Associate Director, Head of Process Sciences Formulation and Fill / Finish
17.6. Synegene
17.6.1. CompanySnapshot
17.6.2. Interview Transcript: Purushottam Singnurkar,Research Director and Head of Formulation Development
17.7. IDEO
17.7.1. CompanySnapshot
17.7.2. InterviewTranscript: Jesse Fourt, Design Director
18. APPENDIX 1:TABULATED DATA
19. APPENDIX 2:LIST OF COMPANIES
Contact Details
Gaurav Chaudhary
+1 (415) 800 3415
